Proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit.
Multiparametric magnetic resonance imaging (MRI)-based machine learning techniques have the potential to identify B-cell lymphoma-6 (BCL-6) overexpression in patients with primary central nervous ...
Circulating kidney injury molecule-1 (KIM-1) predicts survival outcomes in patients with metastatic renal cell carcinoma (mRCC), even in patients who have coexisting acute kidney injury (AKI) or ...
We think that PORTOS could be used to help guide radiation dose-escalation and de-escalation in both the post-operative and definitive settings,” said Shuang (George) Zhao, MD.
Researchers developed an approach for interpreting data from online patient narratives that would address concerns such as source credibility and limited background information.
Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, California, ...
Researchers explored the effects of technology-based empowerment interventions on distress, depression, anxiety, resilience, and coping in parents of children with cancer.
Among those with a TBS score less than 6 and node-negative disease, 5-year OS was similar between those receiving AC and those who did not.
High-dose methotrexate (HD-MTX) with the modified Bonn protocol including intrathecal therapy is effective for patients less than 65 years old with primary central nervous system lymphoma (PCNSL), ...
Updated data "reinforce enfortumab vedotin and pembrolizumab as the new standard of care in frontline urothelial cancer,” said Thomas Powles, MD, MBBS.
Physical activity attenuates survival disparity between patients with stage III colon cancer and matched population controls.
Investigators compared a urinary DNA methylation test with the nuclear matrix protein 22 (NMP22) and urine cytology tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results